Galanin was first identified 30 years ago as a" classic neuropeptide," with actions primarily
as a modulator of neurotransmission in the brain and peripheral nervous system. Other …

Alzheimer's disease (AD) is characterized by a progressive phenotypic downregulation of
markers within cholinergic basal forebrain (CBF) neurons, frank CBF cell loss and reduced …

The Eleventh Eilat Conference on New Antiepileptic Drugs (AEDs)-EILAT XI, took place in
Eilat, Israel from the 6th to 10th of May 2012. About 100 basic scientists, clinical …

The galanin peptide family consists of the “parental” galanin, galanin-message-associated
peptide (GMAP) which derives from the same peptide precursor gene product as galanin …

The neuropeptide galanin was first discovered 30 years ago. Today, the galanin family
consists of galanin, galanin-like peptide (GALP), galanin-message associated peptide …

Unlike its central counterpart, the peripheral nervous system is well known for its
comparatively good potential for regeneration following nerve fiber injury. This ability is …

The expression of the neuropeptide galanin is markedly up-regulated in many areas of the
central and peripheral nervous system after injury. We have recently demonstrated that …

Expression of the neuropeptide galanin is up‐regulated in many brain regions following
nerve injury and in the basal forebrain of patients with Alzheimer's disease. We have …

Acute myocardial infarction (AMI) and the heart failure (HF) that often complicates this
condition, are among the leading causes of death and disability worldwide. To reduce …

Galanin is a highly inducible neuropeptide, showing distinct up-regulation after pathological
disturbance within the nervous system. Significant increase in galanin expression is …